Suzanne E. Davis
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Hepatocellular Carcinoma Treatment and Prognosis, Colorectal Cancer Treatments and Studies, Economic and Financial Impacts of Cancer, Ethics in Clinical Research
Most-Cited Works
- → Chimeric antigen receptor T-cell therapy — assessment and management of toxicities(2017)2,299 cited
- → The BATTLE Trial: Personalizing Therapy for Lung Cancer(2011)885 cited
- → The Efficacy and Safety of Fluticasone Propionate (250 μg)/Salmeterol (50 μg) Combined in the Diskus Inhaler for the Treatment of COPD(2003)327 cited
- → Methodological and practical challenges for personalized cancer therapies(2011)184 cited
- → Image-Guided Biopsy in the Era of Personalized Cancer Care: Proceedings from the Society of Interventional Radiology Research Consensus Panel(2015)112 cited
- → Comprehensive Biomarker Analysis and Final Efficacy Results of Sorafenib in the BATTLE Trial(2013)64 cited
- → The Carotid Chemoreceptors are a Major Determinant of Ventilatory CO2 Sensitivity and of PaCO2 During Eupneic Breathing(2007)49 cited
- → Clinical Trial Characteristics and Barriers to Participant Accrual: The MD Anderson Cancer Center Experience over 30 years, a Historical Foundation for Trial Improvement(2017)35 cited
- → Clinical Outcomes and Biomarker Profiles of Elderly Pretreated NSCLC Patients from the BATTLE Trial(2012)23 cited
- → Clinical and Biomarker Outcomes of the Phase II Vandetanib Study from the BATTLE Trial(2013)22 cited